Nicolas Barthelemy insider trades: Repligen (RGEN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nicolas reports to the SEC
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | RGEN | ↑ Buy | 1,200 | $125.45 | $151K | Direct | Jun 14, 2024 (0d) |
| May 11, 2022 | TWST | ↑ Buy | 8,550 | $29.25 | $250K | Direct | May 13, 2022 (2d) |
| Oct 29, 2021 | RGEN | ↓ Sell | 1,645 | $288.20 | $474K | Direct | Nov 2, 2021 (4d) |
| Jun 24, 2021 | MASS | ↓ Sell | 7,000 | $39.80 | $279K | Direct | Jun 25, 2021 (1d) |
| Jun 23, 2021 | MASS | ↓ Sell | 6,000 | $39.63 | $238K | Indirect | Jun 25, 2021 (2d) |
| Feb 9, 2021 | TWST | ↓ Sell | 5,000 | $177.61 | $888K | Direct | Feb 11, 2021 (2d) |
| Dec 22, 2020 | MASS | ↑ Buy | 14,000 | $20.00 | $280K | Direct | Dec 22, 2020 (0d) |
| Nov 9, 2020 | RGEN | ↓ Sell | 1,214 | $195.51 | $237K | Direct | Nov 10, 2020 (1d) |
| May 18, 2020 | RGEN | ↓ Sell | 3,009 | $142.53 | $429K | Direct | May 26, 2020 (8d) |
| Apr 22, 2020 | RGEN | ↓ Sell | 2,688 | $109.99 | $296K | Direct | Apr 24, 2020 (2d) |
| Apr 3, 2020 | RGEN | ↓ Sell | 2,688 | $99.99 | $269K | Direct | Apr 6, 2020 (3d) |
| Mar 6, 2020 | FLDM | ↑ Buy | 80,000 | $3.05 | $244K | The Barthelemy 2001 Trust | Mar 10, 2020 (4d) |
| Feb 13, 2020 | FLDM | ↑ Buy | 12,257 | $3.64 | $45K | The Barthelemy 2001 Trust | Feb 18, 2020 (5d) |
| Jun 17, 2019 | FLDM | ↓ Sell | 5,100 | $12.43 | $63K | The Barthelemy 2001 Trust | Jun 19, 2019 (2d) |
| Aug 29, 2018 | RGEN | ↓ Sell | 6,580 | $54.44 | $358K | Direct | Aug 31, 2018 (2d) |
| May 9, 2018 | RGEN | ↓ Sell | 26,500 | $40.54 | $1.1M | Direct | May 11, 2018 (2d) |
| Dec 10, 2010 | LIFE | ↓ Sell | 31,208 | $52.80 | $1.6M | Direct | Dec 13, 2010 (3d) |
| Apr 29, 2010 | LIFE | ↓ Sell | 14,781 | $55.00 | $813K | Direct | May 3, 2010 (4d) |
| Mar 16, 2010 | LIFE | ↓ Sell | 17,132 | $53.00 | $908K | Direct | Mar 17, 2010 (1d) |
| Mar 2, 2010 | LIFE | ↓ Sell | 1,603 | $51.41 | $82K | Direct | Mar 3, 2010 (1d) |
| Dec 15, 2009 | LIFE | ↓ Sell | 5,300 | $52.00 | $276K | Direct | Dec 16, 2009 (1d) |
| Nov 23, 2009 | LIFE | ↓ Sell | 15,000 | $49.90 | $749K | Direct | Nov 24, 2009 (1d) |
| Nov 16, 2009 | LIFE | ↓ Sell | 5,000 | $50.38 | $252K | Direct | Nov 17, 2009 (1d) |
| Jul 30, 2009 | LIFE | ↓ Sell | 6,500 | $47.00 | $306K | Direct | Aug 3, 2009 (4d) |
| Jun 2, 2009 | LIFE | ↓ Sell | 3,000 | $39.90 | $120K | Direct | Jun 3, 2009 (1d) |
| May 13, 2009 | LIFE | ↓ Sell | 4,626 | $36.50 | $169K | Direct | May 15, 2009 (2d) |
| May 1, 2009 | LIFE | ↓ Sell | 352 | $36.45 | $13K | Direct | May 5, 2009 (4d) |
| Apr 29, 2009 | LIFE | ↓ Sell | 7,084 | $35.64 | $253K | Direct | May 1, 2009 (2d) |
| Apr 23, 2008 | IVGN | ↓ Sell | 2,500 | $93.00 | $233K | Direct | Apr 25, 2008 (2d) |
| Mar 27, 2008 | IVGN | ↓ Sell | 2,500 | $85.62 | $214K | Direct | Mar 27, 2008 (0d) |
| Nov 26, 2007 | IVGN | ↓ Sell | 13,579 | $95.00 | $1.3M | Direct | Nov 28, 2007 (2d) |
| Nov 15, 2007 | IVGN | ↓ Sell10b5-1 | 3,531 | $90.18 | $318K | Direct | Nov 16, 2007 (1d) |
| Nov 12, 2007 | IVGN | ↓ Sell | 3,250 | $90.00 | $293K | Direct | Nov 14, 2007 (2d) |
| Oct 31, 2007 | IVGN | ↓ Sell | 22,268 | $89.02 | $2.0M | Direct | Nov 2, 2007 (2d) |
| Oct 18, 2007 | IVGN | ↓ Sell | 5,640 | $84.52 | $477K | Direct | Oct 22, 2007 (4d) |
| Jul 10, 2007 | IVGN | ↓ Sell | 7,250 | $75.00 | $544K | Direct | Jul 12, 2007 (2d) |
| Jun 15, 2007 | IVGN | ↓ Sell | 3,250 | $75.00 | $244K | Direct | Sep 10, 2007 (87d) |
| Jun 11, 2007 | IVGN | ↓ Sell | 437 | $74.00 | $32K | Direct | Jun 12, 2007 (1d) |
| May 15, 2007 | IVGN | ↓ Sell | 1,617 | $71.81 | $116K | Direct | May 17, 2007 (2d) |
| Aug 7, 2006 | IVGN | ↑ Buy | 2,700 | $56.24 | $152K | Direct | Aug 8, 2006 (1d) |
| Mar 13, 2006 | IVGN | ↓ Sell | 5,000 | $69.71 | $349K | Direct | Mar 14, 2006 (1d) |
| Aug 3, 2005 | IVGN | ↓ Sell | 500 | $85.93 | $43K | Direct | Aug 5, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RGEN insiders
Open-market trades in the last 12 months
About Nicolas Barthelemy's insider trades
Nicolas Barthelemy is an insider at Repligen (RGEN). Since Aug 3, 2005, Nicolas has reported 6 open-market purchases worth $1.1M and 36 sales worth $16.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (2% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include option exercises (44 filings), grants and awards (39 filings), shares withheld for taxes (7 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RGEN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.